Prevention Works is a holistic approach to swine health built on our range of innovative world-class vaccines complemented by:
Our goal is going from prevention to prediction and beyond
The Swine Health content site. Curated for you with love.
“We know that vaccinating can decrease the amount of viruses in the air, so vaccination is a good mechanism to prevent airborne transmission” Swine veterinary consultant Dr. Carmen Alonso in Spain picks out lessons from her detailed studies of air samples inside and outside farms suffering an outbreak of PRRS, influenza A or porcine epidemic diarrhoea --- as well as poultry sites with highly pathogenic avian influenza.
Rutger Jansen
“Our recent work demonstrated the presence of the PCV-3 genome within mild-to moderate histological lesions of aborted fetuses.
In this video Dr. Mike Murtaugh discusses vaccine cross-protection on various PCV2 strains: PCV2a, PCV2b & PCV2d. He also talks about the outbreaks of PCVAD and how correct usage of the vaccine is key.
Prof Joaquim Segalés and Dr Oliver Duran Porcine circovirus type 2 (PCV2) was initially detected in the late 1990s in North America and Europe associated with a post weaning multisystemic wasting syndrome in pigs.
Greg Stevenson
Get the latest news on Swine Health Subscribe to our newsletter
Boehringer Ingelheim Vetmedica, Inc. (BIVI) is inviting proposals for the annual Boehringer Ingelheim Advancement in PRRS Research Award Program.
US – Governor Terry E. Branstad travelled to Sioux Center last week to attend the grand opening for one of three Boehringer Ingelheim Vetmedica, Inc. (BIVI) specialised vaccine research facilities.
BARCELONA, SPAIN - An important anniversary in the history of porcine circovirus type 2 (PCV2) has been marked at a special international pig veterinary satellite symposium held in Barcelona, Spain in June 2011 as part of the 6th International Symposium on Emerging and Re-emerging Pig Diseases.
4th Boehringer Ingelheim Expert Forum on Farm-Animal Well-Being
Boehringer Ingelheim has laid the foundation stone for its European Veterinary Research Center in Hanover.
The EU Commission has approved the simultaneous use of the pig vaccines Ingelvac CircoFLEX® and Ingelvac MycoFLEX® in the European Union. Boehringer Ingelheim will market this unique vaccine concept under the name FLEXcombo®.